← Open Payments lookup

BENJAMIN DAHUNSI: Open Payments

NPI 1225535206 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$635 in 26 payments from 10 companies in 2025. Trend: 2023 $1,966 · 2024 $1,203 · 2025 $635

Food & beverage: $635
CompanyPaymentsAmount
Axsome Therapeutics, Inc.5$119
Almatica Pharma LLC5$99
Takeda Pharmaceuticals U.S.A., Inc.2$66
Alkermes, Inc.3$63
Neurocrine BioSciences, Inc.2$59
Lundbeck LLC2$52
E.R. Squibb & Sons, L.L.C.2$51
ABBVIE INC.2$49
Janssen Pharmaceuticals, Inc2$48
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$28

Products named: Auvelity, LOREEV XR, TRINTELLIX, ARISTADA, INGREZZA, COBENFY, VRAYLAR, INVEGA SUSTENNA.

Industry payments across MD — which companies pay providers there.